. Development of Assaying Plasma TDP-43 Utilizing Immunomagnetic Reduction. Journal of Neurological Disorders. November 4, 2020. Neurol Disord.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Taiwan FDA Approves MagQu Plasma Aβ And Tau Tests